Bate G
Am J Clin Pathol. 1986 Jun;85(6):716-8. doi: 10.1093/ajcp/85.6.716.
Three commercial anaerobic systems, Minitek (BBL Microbiology Systems, Cockeysville, MD), API An-Ident (Analytab Products, Plainview, NY), and RapID ANA (Innovative Diagnostic Systems, Decatur, GA) were evaluated for ability to identify 45 Clostridium difficile isolates accurately. Minitek correctly identified 66% of C. difficile isolates to species, 27% were incompletely identified, and 7% were misidentified. Most of the discrepancies with Minitek were due to false negative biochemical results. API An-Ident correctly identified 9% C. difficile isolates to species, 89% were incompletely identified, and 2% were misidentified. Most of the API An-Ident discrepancies were due to the data base, which distinguished poorly between C. difficile, Clostridium hastiforme, and Clostridium sporogenes. RapID ANA correctly identified 100% of C. difficile isolates.
对三种商用厌氧系统Minitek(BBL微生物系统公司,马里兰州科基斯维尔)、API An-Ident(Analytab产品公司,纽约州普莱恩维尤)和RapID ANA(创新诊断系统公司,佐治亚州迪凯特)进行了评估,以确定其准确鉴定45株艰难梭菌分离株的能力。Minitek能将66%的艰难梭菌分离株正确鉴定到种,27%鉴定不完全,7%鉴定错误。与Minitek的大多数差异是由于生化结果假阴性。API An-Ident能将9%的艰难梭菌分离株正确鉴定到种,89%鉴定不完全,2%鉴定错误。API An-Ident的大多数差异是由于数据库,该数据库难以区分艰难梭菌、梭形梭菌和产芽孢梭菌。RapID ANA能将100%的艰难梭菌分离株正确鉴定。